The evaluation of fetal intrapartum resuscitation methods for categoryⅡ fetal heart monitoring

doi:10.3877/cma.j.issn.2095-3259.2020.03.004

Abstract

Abstract:

Electronic fetal monitoring(EFM)during labor is one of means to evaluate the fetal intrauterine state. Category Ⅱ pattern is a suspicious fetal heart rate monitoring pattern, which is common in clinic. Its manifestation is different and atypical. It suggests that the fetus is in suspicious distress in utero. For this kind of pattern, it is necessary to correctly identify, interpret, carry out necessary clinical interventions, such as intrauterine resuscitation, and subsequent reevaluation. This paper mainly introduces various methods of intrauterine resuscitation and the evaluation of various methods of resuscitation.

Key words: Category Ⅱ electronic fetal monitoring, Intrauterine resuscitation

Lin Qu, Lizhou Sun. The evaluation of fetal intrapartum resuscitation methods for categoryⅡ fetal heart monitoring[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2020, 09(03): 140-144.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhckjjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3259.2020.03.004

https://zhckjjdzzz.cma-cmc.com.cn/EN/Y2020/V09/I03/140

References 25

[1]	American College of Obstetricians and Gynecologists. Practice bulletin no.116：Management of intrapartum fetal heart rate tracings[J]. Obstet Gynecol, 2010, 116(5):1232-1240.
[2]	中华医学会围产医学分会．电子胎心监护应用专家共识[J]. 中华围产医学杂志，2015,18(7):486-490.
[3]	Macones GA, Hankins GD, Spong CY, et al. The 2008 National Institute of Child Health and Human Development workshop report on electronic fetal monitoring: update on definitions，interpretation，and research guidelines [J]. Obstet Gynecol，2008, 112(3):661-666.
[4]	Gary D V Hankins, Michael Speer. Defining the Pathogenesis and Pathophysiology of Neonatal Encephalopathy and Cerebral Palsy[J]. Obstet Gynecol, 2003, 102(3):628-636.
[5]	Simpson KR, James DC.Efficacy of intrauterine resuscitation techniques in improving fetal oxygen status during labor[J]．Obstet Gynecol，2005,105(6):1362-1368.
[6]	Kinsella SM, Thurlow JA.P1acental oxygen transfer and intrauterine resuscitation：a survey of knowledge in maternity care professionals [J]．Int J Obstet Anesth，2000,9(1):15-19.
[7]	Haydon ML, Gorenberg DM, Nageotte MP，et al. The effect of maternal oxygen administration on fetal pulse oximetry during labor in fetuses with nonreassuring fetal heart rate patterns[J]. Am J Obstet Gynecol, 2006, 195(3): 735-738.
[8]	Fawole B, Hofmeyr GJ.Maternal oxygen administration for fetal distress [J]. Cochraue Database Syst Rev，2012,12(12):CD000136.
[9]	Hamel MS, Anderson BL, Rouse DJ. Oxygen for intrauterine resuscitation：of unproved benefit and potentially harmful[J]. Am J Obstet Gynecol, 2014, 211(2):l24-127.
[10]	Simpson KR. Intrauterine resuscitation during labor：should maternal oxygen administration be a first-line measure？[J]．Semin Fetal Neonatal Med, 2008, 13(6):362-367.
[11]	Mihwa S, Hirofumi H, Midori T, et al.Thrombomodulin improves maternal and fetal conditions in an experimental pre-eclampsia rat model[J]. J Obstet Gynaecol, 2014, 40(5): 1226-1234.
[12]	石燕燕，吴牡玲，刘珈宸. 林格氏液改善胎儿宫内窘迫减少新生儿窒息临床效果观察[J]. 中国医学创新，2017, 14(18): 90-93.
[13]	Eslamian L, Marsoosi V, Pakneeyat Y. Increased intravenous fluid intake and the course of labor in nulliparous women [J]. Int J Gynaecol Obstet, 2006, 93(2):102-105.
[14]	Macones GA, Hankins GD, Spong CY，et al.The 2008 National Institute of Child Health and Human Development workshop repoon electronic fetal monitoring: update on definitions，interpretation，and research guide lines[J]．J Obstet Gynecol Neonatal Nurs, 2008, 37(5):510-5l5.
[15]	National Institute of Health and Clinical Excellence.Intrapartum care：care of Healthy women and their babies during childbirth.NICE ClinicalGuideline，No.190[M]．London：NICE，2014：537-571.
[16]	ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No.107：Induction of labor [J]．Obstet Gynecol，2009,114(2Pt1):386-397.
[17]	van Vliet EOG, Nijman TAJ, Schuit E，et al. Nifedipine versus atosiban for threatened preterm birth(APOSTEL Ⅲ): a multicentre，randomised controlled trial[J]. Lancet，2016,387(10033): 2117-2124.
[18]	Doyle LW, Crowther CA, Middleton P，et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus [J]. Cochrane Database Syst Rev，2009,(1):CD004661.
[19]	Magee LA, De Silva DA, Sawchuck D, et al. No.376-Magnesium sulphate for fetal neuroprotection [J]. J Obstet Gynaecol Can, 2019, 41(4): 505-522.
[20]	Vigil-De GP, Simiti E, Lora Y. Intrapartum fetal distress and magnesium sulfate [J]．Int J Gynaecol Obstet, 2000, 68(1): 3-6.
[21]	Leduc D, Biringer A, Lee L, et al. Induction of labour [J]. J Obstet Gynaecol Can, 2013, 35(9):840-857.
[22]	Rinehart BK, Terrone DA, Barrow JH, et al. Randomized Trial of Intermittent or Continuous Amnioinfusion for Variable Decelerations [J]. Obstet Gynecol, 2000, 96(4): 571-574.
[23]	Fraser WD, Hofmeyr J, Lede R, et al. Amnioinfusion for the prevention of the meconium aspiration syndrome[J]. N Engl J Med, 2005, 353(9):909-917.
[24]	Novikova N, Hofmeyr GJ, Essilfie-Appiah G. Prophylactic versus the rapeutic amnioinfusion for oligohydramnios in labour [J]. Cochrane Database Syst Rev，2012,(9):CD000176.
[25]	李敏，邹丽，朱剑文，等. 羊膜腔灌注治疗产时频发可变减速142例分析[J]．中国实用妇科与产科杂志，2002, 18(2):106-108.

Please choose a citation manager

Content to export